KNG1 and liver dysplastic nodule: In individuals with T1D and no clinical evidence of DN we found several modest associations between higher baseline concentrations of bradykinin and related peptides and preserved kidney structures over the 5 years of RASS, suggesting that these bradykinins may have a reno-protective role in T1D before the onset of clinically detectable DN.